Goose Down Allergy: Feather Duvet Lung, IgE Testing, and the Bedding Paradox

According to Kilpiö et al. (Allergy 1998), 12 of 269 tested adults showed IgE sensitization to goose feathers compared to only 2 of 269 for duck feathers — a 4.5% versus 0.7% rate. So in terms of true IgE sensitization to the feather proteins themselves, goose is more sensitizing than duck when allergy does occur. However, both rates are low, and the clinical significance of this difference is modest. For feather duvet lung (HP), both duck and goose down are equally implicated. For the much more common dust mite allergy facilitated by down bedding, the species of bird is irrelevant — what matters is casing quality and washing frequency.

Yes — feather duvet lung is a form of hypersensitivity pneumonitis caused by inhaling avian proteins from goose (and duck) down bedding. It is a serious condition that can progress to pulmonary fibrosis if unrecognized. Forty percent of HP cases at one referral center involved patients using goose or duck down bedding (Jacobs et al., Ann Allergy Asthma Immunol 2019). The condition develops insidiously over months to years of nightly exposure — not as an immediate allergic reaction. Any person with long-term goose down use who experiences progressive exertional breathlessness, chronic dry cough, and fatigue should seek pulmonologist evaluation including chest HRCT, not simply antihistamine treatment.

Counterintuitively, the evidence suggests they can be — under specific conditions. Strachan & Carey (BMJ 1995), Butland et al. (Thorax 1997), and Ponsonby et al. (Allergy 2002) all found that children using feather pillows had lower rates of severe wheeze and dust mite sensitization than those using synthetic pillows. The explanation is the barrier effect: tightly woven down-proof fabric casings prevent house dust mite penetration into the down fill, reducing mite allergen exposure. Synthetic fill in loosely woven covers provides no such barrier. This paradox only applies to properly certified, tightly woven feather bedding — not to old, uncertified, or loosely cased down products, and not for patients with true goose feather IgE allergy or feather duvet lung.

The most reliable approach is a two-part assessment. First, get allergy testing — specific IgE to dust mite components (Der p 1 and Der p 2) and goose feather extract — to identify which proteins are driving IgE sensitization. Most bedding-reactive patients test positive for mite, not goose feather. Second, if progressive breathlessness rather than immediate rhinitis is the pattern, arrange pulmonologist evaluation with HRCT to assess for feather duvet lung. A simple 4–8 week trial of removing the goose duvet and replacing with a synthetic alternative while keeping a symptom diary can also provide useful clinical information — though the result must be interpreted knowing that the change removes multiple variables simultaneously.

NOMITE is a certification for feather and down bedding products confirming that the fabric casing prevents house dust mite penetration. Products are tested according to standards developed by the European Committee for Standardization; the NOMITE label guarantees that the casing weave is dense enough to block mite entry into the down fill. For dust mite-allergic patients who wish to keep feather bedding, NOMITE certification is the most important quality indicator — it is what enables the paradoxical protective effect described in Strachan 1995 and Ponsonby 2002. Without tight-weave certification, feather bedding provides no mite barrier advantage. NOMITE certification does not protect against feather duvet lung risk, which depends on the processing and washing of the down fill itself.

For IgE-mediated allergy, the sensitizing proteins are in the feather material itself — the same conserved avian serum albumin (67 kDa band) and proteins in the 20–30 kDa range documented across avian species by Tauer-Reich et al. 1994. For feather duvet lung (HP), the antigens are avian serum proteins (albumin and immunoglobulins) embedded in the down filling — derived from the bird's blood proteins during feather development. In the context of contact with live geese outdoors, droppings contribute additional avian antigen exposure; dried goose droppings contain avian proteins that become airborne when disturbed. However, for the bedding-related conditions that are most clinically relevant, the source is the processed down fill, not fresh droppings.

Potentially yes — with the right precautions. NOMITE-certified, properly cased goose down provides a physical barrier against mite penetration that comparable synthetic alternatives may lack. The evidence from Strachan 1995, Butland 1997, and Ponsonby 2002 suggests that feather pillow users have lower rates of mite sensitization than synthetic pillow users — consistent with the casing barrier effect. If you want to keep your goose down, invest in NOMITE-certified casings for the duvet and pillows, wash the removable covers weekly at above 54°C, and replace the duvet itself at least every 5–7 years. Combined with dust mite SLIT if your IgE testing confirms mite sensitization, this approach is medically defensible. If you have progressive dyspnea rather than rhinitis, feather duvet lung must be evaluated first.

Both are forms of hypersensitivity pneumonitis (Type III/IV) caused by inhaled avian proteins, sharing the same immune mechanism: IgG antibodies, immune complex formation, and T-cell granulomatous inflammation in the alveolar space. The difference is the exposure source and the dose pattern. Pigeon fancier's lung arises from active pigeon keeping — handling birds, cleaning lofts, attending shows — creating periodic high-dose exposures that can produce acute febrile episodes (fever and chills 4–8 hours post-exposure). Feather duvet lung arises from nightly low-dose exposure to down in bedding, producing a more insidious chronic progression without acute febrile episodes. Both can cause irreversible fibrosis; both require complete avoidance of the antigen source; neither responds to sublingual immunotherapy or allergy shots.